Articles by Lynn D. Torbeck - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Lynn D. Torbeck

The Matrixx Zicam Verdict

The authors summarize the Matrixx Initiatives, Inc. v. Siracusano case's implications for industry.
Oct 2, 2011

The authors summarize the Matrixx Initiatives, Inc. v. Siracusano case's implications for industry.

Reducing the Risk in Risk Management

A firm grasp of probability and ongoing re-evaluation are key.
Aug 2, 2011

A firm grasp of probability and ongoing re-evaluation are key.

Statistics in the Service of Quality

Ensuring compliance though increased statistical knowledge and resources.
Jun 2, 2011

Ensuring compliance though increased statistical knowledge and resources.

Pitfalls in Statistics

The hardest errors to spot are the ones that don't look like errors at all.
Apr 2, 2011

The hardest errors to spot are the ones that don't look like errors at all.

FDA Perspectives: An Initial Report of CDER's Recall Root Cause Research Project (Part II)

The authors discuss how their research will help FDA in its identification of areas of emphasis in pre- and postapproval evaluation of products and processes.
Jan 2, 2011

The authors discuss how their research will help FDA in its identification of areas of emphasis in pre- and postapproval evaluation of products and processes.

Walk Like a Statistician

Applied statisticians are forever searching for the enemy of quality—variability.
Nov 2, 2010

Applied statisticians are forever searching for the enemy of quality—variability.

Statistical Solutions: Visual Inspection Goes Viral

To properly inspect based on measurement, a reference standard is crucial for comparison.
Sep 2, 2010

To properly inspect based on measurement, a reference standard is crucial for comparison.

Statistical Solutions: On the Verge of Significance: Why 5%

A history of the selection of the widely used significance level leaves much to be desired.
Jul 2, 2010

A history of the selection of the widely used significance level leaves much to be desired.

Statistical Solutions: Bergum's Method Recognized

A method for determining sample size is finally getting some respect.
May 2, 2010

A method for determining sample size is finally getting some respect.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here